Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

292
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
292
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

790
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
790
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

668
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
668
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

403
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
403
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

80
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
80
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orientation microscopy study of cryogenic-temperature friction stir processed AA6xxx sheet: microstructure and second phase particles evolution.

Applied microscopy·2026
Same author

Mediastinal over-staging with PET-CT in tuberculosis-endemic locally advanced NSCLC: SUV threshold recalibration improves PET/EBUS concordance.

European journal of nuclear medicine and molecular imaging·2026
Same author

A Machine Learning Framework for the Reconstruction of Composite Fatigue and Fracture Properties: A Synthetic Data Study.

Materials (Basel, Switzerland)·2026
Same author

WxC-Bench: A Novel Dataset for Weather and Climate Downstream Tasks.

Scientific data·2026
Same author

A Deep Learning-based Method for Detection of Severity Stages of Otitis Media by Otoscopic Images.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Atrial fibrillation following patent foramen ovale closure: A large single-center institutional experience.

Cardiovascular revascularization medicine : including molecular interventions·2025

Related Experiment Video

Updated: Mar 9, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.1K

Kawasaki disease for dermatologists.

Aman Gupta1, Surjit Singh1

  • 1Allergy Immunology Unit, Department of Pediatrics, PGIMER, Chandigarh, India.

Indian Dermatology Online Journal
|December 20, 2016
PubMed
Summary

Kawasaki disease (KD) is a childhood vasculitis affecting medium arteries. Early diagnosis, especially for incomplete KD, is crucial to prevent coronary artery abnormalities (CAAs) through prompt treatment with IVIG and aspirin.

Keywords:
Coronary artery abnormalitiesKawasaki diseasedermatologic manifestationsintravenous immunoglobulin

More Related Videos

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

786
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 9, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.1K
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

786
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

1.3K

Area of Science:

  • Pediatric Rheumatology
  • Systemic Vasculitis
  • Pediatric Cardiology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children, characterized by systemic vasculitis affecting medium-sized arteries, particularly the coronaries.
  • The exact etiology of KD remains unknown, with proposed links to microbial agents, superantigens, and genetic predisposition.
  • Diagnosis is primarily clinical, based on prolonged fever and characteristic physical findings, with no definitive laboratory test available.

Approach:

  • Clinical diagnosis relies on identifying key features such as fever, rash, extremity changes, mucosal involvement, conjunctivitis, and lymphadenopathy.
  • Special attention is given to 'incomplete KD,' often presenting in infants with fewer than four principal features, necessitating thorough dermatological evaluation.
  • The study emphasizes the importance of recognizing evolving symptoms for timely diagnosis and intervention.

Key Points:

  • Coronary artery abnormalities (CAAs), including dilatations and aneurysms, develop in up to 25% of untreated KD patients and are a major cause of morbidity and mortality.
  • Prompt diagnosis of both complete and incomplete KD is vital to mitigate the risk of developing CAAs.
  • Dermatological examination plays a critical role in identifying subtle or evolving signs, especially in cases of incomplete KD.

Conclusions:

  • Kawasaki disease requires vigilant clinical assessment, particularly for incomplete presentations, to prevent severe cardiovascular complications.
  • Intravenous immunoglobulin (IVIG) and aspirin are the primary treatments to reduce inflammation and prevent CAAs.
  • Long-term follow-up is essential for all KD patients due to the persistent risk of developing coronary artery abnormalities despite treatment.